Axsome Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| General Public | 569,854 | 1.2% |
| Individual Insiders | 656,429 | 1.38% |
| Hedge Funds | 4,489,596 | 9.45% |
| Private Companies | 7,351,026 | 15.5% |
| Institutions | 34,426,415 | 72.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 7,344,500 | US$550.0m | 0% | no data | |||
| 4,489,596 | US$336.2m | 0% | 5.8% | |||
| 3,696,766 | US$276.9m | -0.87% | no data | |||
| 3,239,746 | US$242.6m | 10.4% | no data | |||
| 2,360,077 | US$176.7m | 0.8% | 17.28% | |||
| 1,981,100 | US$148.4m | -7.04% | 3.57% | |||
| 1,089,085 | US$81.6m | -15.9% | 0.08% | |||
| 1,038,019 | US$77.7m | 116% | 1.77% | |||
| 1,000,000 | US$74.9m | -12.3% | 2.47% | |||
| 1,000,000 | US$74.9m | 0% | 0.99% | |||
| 924,190 | US$69.2m | 6.52% | no data | |||
| 909,965 | US$68.1m | 80.9% | 0.06% | |||
| 881,951 | US$66.0m | -52.6% | no data | |||
| 837,201 | US$62.7m | 57.4% | 0.13% | |||
| 822,304 | US$61.6m | 5.63% | 0.01% | |||
| 752,044 | US$56.3m | -0.89% | 56.82% | |||
| 698,932 | US$52.3m | 8.12% | 0.04% | |||
| 635,372 | US$47.6m | 0.62% | 0.53% | |||
| 578,422 | US$43.3m | 126% | 0.01% | |||
| 563,335 | US$42.2m | 1.83% | 0.79% | |||
| 562,163 | US$42.1m | 24.3% | 0.45% | |||
| 467,427 | US$35.0m | -10.7% | 2.13% | |||
| 459,400 | US$34.4m | 54.8% | 1.3% | |||
| 428,953 | US$32.1m | 0% | no data | |||
| 400,000 | US$30.0m | 0% | 1.72% |